<DOC>
	<DOCNO>NCT00454740</DOCNO>
	<brief_summary>To evaluate efficacy 5 and10mg solifenacin succinate patient urgency OAB syndrome ( urgency , without urge incontinence , usually frequency nocturia ) wish switch tolterodine tartrate extend release solifenacin succinate due lack sufficient improvement urgency episode</brief_summary>
	<brief_title>Efficacy &amp; Safety Study VESIcare® ( Solifenacin Succinate ) Patients Wishing Switch From Detrol LA® Treatment Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Patients OAB treat tolterodine tartrate extend release least 4 week immediately precede entry study , wish switch solifenacin succinate due lack sufficient improvement urgency episode . Previous nondrug treatment OAB allow establish least 4 week prior Screening continue throughout study . At least 3 urinary urgency episodes/24 hour receive tolterodine tartrate extend release document 3day patient diary prewashout assessment tolterodine tartrate extend release without urge incontinence describe OAB syndrome . Prior treatment tolterodine tartrate extend release , patient must OAB syndrome 3 month . Previous treatment darifenacin Treatment tolterodine tartrate extend release le 4 week prior enrollment study . Significant stress incontinence mixed stress/urge incontinence stress predominant factor determine investigator . Evidence urinary tract infection ; chronic inflammation interstitial cystitis bladder stone . Clinically significant outflow obstruction determine Investigator Uncontrolled narrow angle glaucoma , urinary gastric retention . All patient severe renal hepatic impairment exclude Patients chronic severe constipation history diagnose gastrointestinal obstructive disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Urinary Bladder , Overactive</keyword>
	<keyword>Urgency</keyword>
	<keyword>VESIcare®</keyword>
	<keyword>Solifenacin succinate</keyword>
</DOC>